Charles River to buy Cambodia-based monkey supplier for $510 million

Core Viewpoint - Charles River Laboratories announced its acquisition of a major supplier of non-human primates for approximately $510 million, aiming to enhance control over procurement processes [1] Company Summary - The acquisition is part of Charles River Laboratories' strategy to strengthen its supply chain and ensure a steady supply of non-human primates, which are critical for its contract research services [1] - The deal reflects the company's commitment to vertical integration within the industry, allowing for better management of resources and potentially reducing costs in the long term [1] Industry Summary - The contract research organization (CRO) sector is increasingly focusing on securing reliable sources of biological materials, such as non-human primates, to meet the growing demand for preclinical research [1] - This acquisition may signal a trend among CROs to consolidate supply chains and enhance operational efficiencies in response to market pressures [1]